HF0220

· Hunter-Fleming Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HF0220, covering 2008-08-21 to 2008-08-21. Get the full timeline:

Most recent: Clinical Trial Update: European Study of HF0220 in Mild to Moderate Alzheimer's Disease Patients [Phase 2]